STAT+: Syndax leukemia drug wins FDA expanded approval

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning, and happy Halloween week. If anyone is dressing up as anything biotech-related, please let me know.

We’ve got several readouts this morning — let’s get into all of it.

Continue to STAT+ to read the full story…

​STAT Pharma: The science and business of new drug development

Leave a Reply

Your email address will not be published. Required fields are marked *